Dominari Holdings is a tiny public financial firm with a market value of about $54.2 million. Yet one private investment vehicle tied to its orbit has reportedly generated paper profits that are many times larger than Dominari’s own public-market value.
Bloomberg reported that American Ventures, a $1 billion private fund that includes presidential sons Donald Trump Jr. and Eric Trump among its investors, has booked hundreds of millions of dollars in unrealized gains by taking stakes in a series of small, thinly traded public companies.
The reported engine of the strategy is not only stock ownership. It is warrants, which can give early investors leveraged exposure if a company’s share price rises after a financing deal.
Dominari announced on February 11, 2025, that Donald Trump Jr. and Eric Trump had joined its advisory board and had participated in a private placement in the company. Dominari said at the time that it was sharpening its focus on data center and artificial intelligence investment opportunities.
Two weeks later, Donald Trump Jr. filed a Schedule 13G showing beneficial ownership of 966,138 Dominari shares, equal to 6.71% of the company as of February 21, 2025. The filing also excluded 432,276 shares issuable through warrants because of beneficial-ownership limits. Eric Trump filed a similar Schedule 13G showing the same 966,138-share position and the same 6.71% ownership figure, also excluding 432,276 warrant-linked shares.
A warrant does not simply mirror a stock position. It can magnify upside because it gives the holder the right to buy shares at a set price. In a microcap, where relatively small flows can move market prices, that structure can create outsized mark-to-market gains before any cash profit is realized.
American Ventures’ role is also visible in public filings. A May 2026 SEC filing by Genius Group Limited said American Ventures was managed by American Ventures Management LLC, in which Dominari holds a 90% membership interest. The same filing said American Ventures was headquartered in Trump Tower, New York, and had participated as sole or lead investor in transactions totaling more than $1.4 billion.
The strategic question is sharper than the headline politics. Dominari and American Ventures appear to be operating at the intersection of capital scarcity and narrative demand. Many microcap companies need financing. Investors want exposure to themes such as AI, drones, crypto, data centers, and domestic manufacturing. The Trump name can add attention to that mix without needing a formal government role.
Dominari has leaned into that positioning. The company describes itself as a Nasdaq-listed holding company focused on “American technology and AI” opportunities, with subsidiaries engaged in wealth management, investment banking, sales and trading, and asset management. It says it invests in companies tied to areas such as AI chip design, data centers, and authentication security.
The company has also responded to political scrutiny before. In March 2026, Dominari said it had received a letter from the House Select Committee on the Strategic Competition Between the US and the Chinese Communist Party about underwriting Chinese IPOs. Dominari said it would cooperate, while adding that IPO revenue had always been less than 10% of its investment banking revenue and that more than 90% came from non-IPO activity.
That statement framed Dominari as a firm pivoting away from China-linked activity and toward American companies. For investors, that is branding. For ethics critics, it is the problem in one sentence. The investment themes overlap with policy priorities promoted by President Donald Trump’s administration, while his sons hold financial interests in the ecosystem arranging or participating in those deals.
No filing reviewed here establishes that Donald Trump Jr. or Eric Trump directed American Ventures’ investments, influenced government policy, or realized cash profits from Bloomberg’s reported microcap gains. One filing involving Genius Group expressly said neither Trump son nor any Trump family member had a direct relationship with that company, its management, or its operations.
Still, the market mechanics are enough to keep regulators, lawmakers, and investors watching.
Microcap finance is built on asymmetry. A small capital raise can reshape a balance sheet. A warrant package can reshape investor economics. A prominent name can reshape attention.
When all three arrive together, the line between ordinary private-market opportunism and political-brand monetization becomes the whole story.